Researchers Test Wireless Implant to Lower Blood Sugar Without Drugs
A new wireless implant developed by researchers at ETH Zurich breaks with traditional diabetes care by using electricity rather than pharmaceuticals to break down excess blood sugar, mdr.de reported. Published in the journal Science, the experimental device targets “diabesity,” the dangerous combination of obesity and type-2 diabetes affecting more than one million people in central Germany alone.
How the Electrocatalytic System Works Inside the Body
The device, named “Echo“, measures roughly one by two centimeters and sits flat beneath the skin in the upper arm or leg, srf.ch reported. The implant consists of graphite felt studded with nanometer-sized gold flakes and smaller platinum particles arranged in spherical structures resembling desert roses. Powered wirelessly via a 13.56 MHz radio frequency, the system relies on electrosynthesis to convert excess blood glucose into gluconate, which is then excreted through urine.
A continuous glucose monitor worn by the patient tracks sugar levels and communicates via Bluetooth with a smartphone, signaling the implant to activate whenever glucose thresholds rise too high after a meal.
In laboratory tests involving obese mice with type-2 diabetes, the system returned blood sugar levels to normal within one hour of activation, according to mdr.de. Over a six-week trial period, the treated animals lost body weight without exhibiting hypoglycemia, inflammation, or behavioral disruptions.
While the laboratory results in rodents show rapid weight reduction and stable blood glucose regulation, independent specialists urge caution regarding human translation. Andreas Birkenfeld noted that this is currently a theoretical future perspective.
Michael Roden highlighted potential clinical risks, including possible technical errors leading to dangerous miscontrol, such as hyper- or hypoglycemia or an overreaction with ketoacidosis. Roden also cautioned that the procedure may not be suitable for everyone, particularly people with type-1 diabetes or long-standing type-2 diabetes where a pronounced insulin deficiency exists, as well as people with impaired liver or kidney function.
Next Steps for Preclinical Animal Trials
The research team plans to advance testing toward larger animal models, such as pigs and sheep, before seeking pathways toward human clinical trials. Christian von Burg, science editor at srf.ch, reported that developers aim to transition the academic prototype into a commercial medical product. Whether the technology ultimately succeeds in human patients remains unproven, leaving the timeline for clinical availability entirely open.
How the glucose implant works
What happens to the converted sugar inside the body?
The implant converts excess glucose into gluconate, which is excreted through urine, according to srf.ch.
Can the implant cause dangerously low blood sugar?
According to srf.ch, the catalyst shuts down automatically once blood sugar reaches the target level, preventing hypoglycemia.
Does the device replace daily insulin injections?
Michael Roden cautioned that the procedure may be problematic for patients with a pronounced insulin deficiency, such as those with type-1 diabetes.
How does the implant receive power?
The device features an internal electronic control unit powered wirelessly via a 13.56 MHz radio frequency.
Keep reading